Latest Operational Updates News

Impact Minerals Limited reported a solid cash position of A$3.75 million at quarter-end, supported by a recent equity raise that extends its funding runway to nearly four quarters despite ongoing exploration expenditures.

Althea Group Holdings reported $5.02 million in Q3 FY25 receipts, driven by strong growth at Peak Canada and the launch of Peak USA, while its pharmaceutical cannabis division faces steep revenue declines prompting strategic review.

Mirvac Group reported a surge in residential sales and advanced capital partnerships for major developments, reaffirming its FY25 earnings guidance amid strong leasing and occupancy across its portfolio.

Stockland’s 3Q25 update highlights steady progress on its Waterloo Renewal Project and solid sales in masterplanned communities, supporting maintained FY25 earnings guidance.

Burgundy Diamond Mines reported a pivotal Q1 2025, completing the transition to Point Lake open pit mining while securing US$73 million in diamond sales and advancing mine life extension plans to 2030 and beyond.

Native Mineral Resources Holdings Limited reported a $3.2 million net cash outflow from operations in Q1 2025 but strengthened its balance sheet with a $4.52 million capital raising post-quarter.

Coronado Global Resources delivered March quarter production in line with plans despite Queensland rainfall, progressing key expansion projects and implementing significant cost reductions to navigate challenging metallurgical coal markets.

Tryptamine Therapeutics has secured a landmark agreement with Swinburne University to initiate the first clinical trial of its IV-infused psilocin formulation TRP-8803 for Binge Eating Disorder, aiming to build on promising Phase 2a data.

Harris Technology Group reported steady Q3 FY25 sales of $3.3 million alongside a modest operating cash outflow, while successfully raising $1.5 million to fuel expansion in refurbished electronics.

Rent.com.au has successfully completed a $1.7 million entitlement issue, positioning itself to expand into loan funding under its RentBond brand while shoring up working capital.

Lumos Diagnostics reported a 21% quarter-on-quarter revenue increase in Q3 FY25, driven by strong product sales and expanded development agreements. The company also secured Medicare coverage in key US regions and advanced its pivotal FebriDx CLIA waiver study with FDA submission expected by year-end.

Catalina Resources has completed its acquisition of the Central Yilgarn Project, unveiling multiple high-grade gold and silver targets, while securing $2.77 million through placement and rights issues to accelerate exploration.